Media-OutReach Newswire Carl Zeiss Meditec AG: Effectiveness and efficiency of targeted intra-operative single dose radiotherapy for breast cancer patients confirmed
Media-OutReach Newswire Sihuan Pharmaceutical’s Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.